Quickly Spot Consensus Among the World's Best Equity Analysts
| Name | Upside % |
Analysts bullish % |
|
|---|---|---|---|
|
170%
upside
4 price targets
|
0
%
|
|
|
|
169%
upside
4 price targets
|
0
%
|
|
|
|
169%
upside
4 price targets
|
0
%
|
|
|
54
Karyopharm Therapeutics
KPTI
$106M
|
168%
upside
4 price targets
|
0
%
|
|
|
167%
upside
4 price targets
|
0
%
|
|
|
|
166%
upside
4 price targets
|
0
%
|
|
|
|
166%
upside
4 price targets
|
0
%
|
|
|
|
166%
upside
4 price targets
|
0
%
|
|
|
|
165%
upside
5 price targets
|
0
%
|
|
|
|
162%
upside
3 price targets
|
0
%
|
|
|
61
Zura Bio
ZURA
$249M
|
161%
upside
3 price targets
|
0
%
|
|
|
156%
upside
4 price targets
|
0
%
|
|
|
|
155%
upside
5 price targets
|
0
%
|
|
|
|
151%
upside
8 price targets
|
0
%
|
|
|
|
150%
upside
3 price targets
|
0
%
|
|
|
|
149%
upside
4 price targets
|
0
%
|
|
|
|
149%
upside
3 price targets
|
0
%
|
|
|
|
148%
upside
3 price targets
|
0
%
|
|
|
|
148%
upside
3 price targets
|
0
%
|
|
|
|
144%
upside
9 price targets
|
0
%
|
|
|
|
139%
upside
3 price targets
|
0
%
|
|
|
|
135%
upside
3 price targets
|
0
%
|
|
|
|
134%
upside
3 price targets
|
0
%
|
|
|
|
132%
upside
7 price targets
|
0
%
|
|
|
|
131%
upside
4 price targets
|
0
%
|
|